ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

FERRLECIT
Anemias
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

FERRLECIT Rx

Generic Name and Formulations:
Iron (as sodium ferric gluconate complex in sucrose) 12.5mg/mL; soln for IV inj or infusion; contains benzyl alcohol.

Company:
Sanofi Aventis

Therapeutic Use:

Indications for FERRLECIT:

Iron deficiency anemia in patients on chronic hemodialysis receiving epoetin therapy.

Adult:

Give by IV infusion (diluted) or slow IV inj (undiluted). 125mg infused over 1 hour or by slow IV inj (at a rate of up to 12.5mg/min). Minimum cumulative dose: 1g given over 8 sequential dialysis sessions; usual max: 125mg/dose.

Children:

<6 yrs: not recommended. Give by IV infusion (diluted) over 1 hour. ≥6yrs: 1.5mg/kg per dose at 8 sequential dialysis sessions; max: 125mg/dose.

Contraindications:

Anemias not caused by iron deficiency. Iron overload. Neonates.

Warnings/Precautions:

Hemoglobinopathies. Refractory anemias. Pregnancy (Cat. B). Nursing mothers.

Interactions:

May reduce absorption of concomitant oral iron preparations.

Pharmacological Class:

Hematinic.

Adverse Reactions:

Hypotension, hypertension, GI upset, chest pain, back pain, abdominal pain, pruritus, inj site reaction, headache, dizziness, syncope, fatigue, fever, cramps, dyspnea, tachycardia; rare: hypersensitivity reactions.

How Supplied:

Ampules (5mL)—10

Sign Up for Free e-newsletters